HIBISCUS study: Exploring the use of a new drug in patients with sickle cell disease

For this year’s Black History Month, we wanted to highlight one of our research studies, HIBISCUS, which is exploring the use of a new drug, Etavopiat, in patients with sickle cell disease.

By NIHR Wellcome King's Clinical Research Facility at 31 Oct 2024

How a framework for remotely enabled co-design benefits a wider project

Effective co-design is essential to research projects that are evaluating new approaches to managing health. Traditionally co-design is carried out face-to-face, but researchers are now developing a framework that enables co-design to be done remotely. Here Anna Morris, Dr Johnny Downs and Stephen Douch write about the FREDY project and how this new framework is helping develop the use of wearables to manage ADHD.  

By NIHR Maudsley BRC at 31 Oct 2024

Multi-site trial uses digital avatars to effectively reduce distressing voices in psychosis

A new multi-site trial from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that a novel therapy using computer-generated avatars is an effective way of helping people with psychosis reduce the distress and frequency with which they hear voices. 

By NIHR Maudsley BRC at 28 Oct 2024

Ancient viral DNA in the human genome linked to multiple sclerosis and amyotrophic lateral sclerosis

New research has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases that affect the central nervous system.

 

By NIHR Maudsley BRC at 23 Oct 2024

First study to show high potency cannabis use leaves unique signature on DNA

High potency cannabis use leaves a distinct mark on DNA, according to new research by the Institute of Psychiatry, Psychology & Neuroscience at King’s College London and the University of Exeter.  

By NIHR Maudsley BRC at 16 Oct 2024